Subtopic Deep Dive

Machine Perfusion for Liver Preservation
Research Guide

What is Machine Perfusion for Liver Preservation?

Machine perfusion for liver preservation uses hypothermic or normothermic ex vivo perfusion systems to maintain and assess liver grafts, reducing ischemic injury compared to static cold storage.

Techniques include hypothermic oxygenated machine perfusion (HOPE) and normothermic machine perfusion (NMP), enabling viability testing of marginal donors after circulatory death (DCD) livers. Randomized trials show reduced biliary complications and improved outcomes (Nasralla et al., 2018; 1150 citations; van Rijn et al., 2021; 555 citations). Over 20 clinical studies compare perfusion to cold storage, expanding transplantable liver pools.

15
Curated Papers
3
Key Challenges

Why It Matters

Machine perfusion resuscitates discarded DCD livers, increasing transplant rates by 20-50% in trials (Mergental et al., 2020; 440 citations). It lowers nonanastomotic biliary strictures from 28% to 6% in DCD transplants (van Rijn et al., 2021). Marginal donors, viable via perfusion, address organ shortages, with first clinical NMP series enabling safe transplantation of high-risk grafts (Ravikumar et al., 2016; 476 citations). Guarrera et al. (2009; 539 citations) demonstrated feasibility in human series, reducing early allograft dysfunction.

Key Research Challenges

Biliary Complications in DCD Livers

Nonanastomotic biliary strictures persist in 10-30% of DCD transplants despite perfusion (van Rijn et al., 2021). HOPE reduces risk but requires optimized protocols for small-for-size grafts. Marginal donor factors compound ischemic cholangiopathy (Busuttil and Tanaka, 2003).

Viability Assessment Metrics

Standardizing biomarkers like ALT, pH, and lactate clearance during NMP remains inconsistent across trials (Nasralla et al., 2018; Mergental et al., 2020). False positives in viability testing discard usable livers. Hypothermic vs. normothermic metrics differ, complicating comparisons (Guarrera et al., 2009).

Scalability to Clinical Practice

High equipment costs and logistics limit adoption beyond trials (Ravikumar et al., 2016). Centers report variable reperfusion injury despite perfusion (Selzner, 2003). Long-term outcomes beyond 1-year need multi-center RCTs.

Essential Papers

1.

A randomized trial of normothermic preservation in liver transplantation

David Nasralla, Constantin Coussios, Hynek Mergental et al. · 2018 · Nature · 1.1K citations

2.

Delayed Graft Function in the Kidney Transplant

Andrew M. Siedlecki, William Irish, Daniel C. Brennan · 2011 · American Journal of Transplantation · 767 citations

3.

The utility of marginal donors in liver transplantation

R. Busuttil, Koichi Tanaka · 2003 · Liver Transplantation · 656 citations

The shortage of organs has led centers to expand their criteria for the acceptance of marginal donors. The combination of multiple marginal factors seems to be additive on graft injury. In this rev...

4.

Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial

Rianne van Rijn, Ivo J. Schurink, Y. de Vries et al. · 2021 · New England Journal of Medicine · 555 citations

Hypothermic oxygenated machine perfusion led to a lower risk of nonanastomotic biliary strictures following the transplantation of livers obtained from donors after circulatory death than conventio...

5.

Protective strategies against ischemic injury of the liver

Nazia Selzner · 2003 · Gastroenterology · 542 citations

6.

Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series

James V. Guarrera, Scot D. Henry, Benjamin Samstein et al. · 2009 · American Journal of Transplantation · 539 citations

7.

Report of a National Conference on Donation after Cardiac Death

James L. Bernat, Anthony M. D’Alessandro, F K Port et al. · 2006 · American Journal of Transplantation · 502 citations

Reading Guide

Foundational Papers

Start with Busuttil and Tanaka (2003; 656 citations) for marginal donor context, then Guarrera et al. (2009; 539 citations) for first HMP clinical data, and Selzner (2003; 542 citations) on ischemic protection strategies.

Recent Advances

Nasralla et al. (2018; 1150 citations) for NMP RCT; van Rijn et al. (2021; 555 citations) HOPE superiority in DCD; Mergental et al. (2020; 440 citations) discarded liver viability.

Core Methods

HOPE uses oxygenated UW perfusate at 10°C (van Rijn); NMP employs blood-based circuits with pH/lactate targets (Nasralla); viability via perfusate biomarkers and bile production (Mergental).

How PapersFlow Helps You Research Machine Perfusion for Liver Preservation

Discover & Search

Research Agent uses searchPapers('hypothermic machine perfusion liver DCD') to retrieve 50+ papers like van Rijn et al. (2021), then citationGraph to map Nasralla et al. (2018) clusters, and findSimilarPapers for HOPE variants. exaSearch uncovers unpublished trial protocols.

Analyze & Verify

Analysis Agent applies readPaperContent on Mergental et al. (2020) to extract viability thresholds, verifyResponse with CoVe against Busuttil and Tanaka (2003) for marginal donor risks, and runPythonAnalysis to plot perfusion outcomes (e.g., pandas on ALT/lactate data). GRADE grading scores Nasralla RCT as high evidence for NMP superiority.

Synthesize & Write

Synthesis Agent detects gaps in long-term biliary data via contradiction flagging between van Rijn (2021) and Guarrera (2009), while Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20+ refs, and latexCompile for trial comparison tables. exportMermaid visualizes HOPE vs. NMP flowcharts.

Use Cases

"Analyze survival curves from Nasralla 2018 NMP trial vs cold storage using Python."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted Kaplan-Meier data) → statistical p-values and plots verifying 10% graft survival benefit.

"Draft LaTeX review comparing HOPE and NMP for DCD livers."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Nasralla/van Rijn) + latexCompile → formatted PDF with tables and synced bibliography.

"Find code for normothermic perfusion simulation models."

Research Agent → paperExtractUrls on Ravikumar 2016 → Code Discovery → paperFindGithubRepo → githubRepoInspect → open-source NMP lactate clearance simulator repo with Jupyter notebooks.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(>50 perfusion papers) → DeepScan (7-step: extract methods → GRADE → Python meta-analysis) → structured report on biliary outcomes. Theorizer generates hypotheses on HOPE+NMP combos from citationGraph of Mergental/van Rijn. DeepScan verifies claims chain: readPaperContent(Nasralla) → CoVe → runPythonAnalysis(survival stats).

Frequently Asked Questions

What is machine perfusion for liver preservation?

Ex vivo systems perfuse livers with oxygenated solutions at hypothermic (4-10°C) or normothermic (37°C) temperatures to extend preservation beyond static cold storage limits.

What are key methods in machine perfusion?

HOPE (van Rijn et al., 2021) oxygenates cold perfusate; NMP (Nasralla et al., 2018) mimics physiology with blood-based circuits monitoring lactate/ALT for viability.

What are seminal papers?

Nasralla et al. (2018; 1150 citations) RCT proves NMP noninferiority; Guarrera et al. (2009; 539 citations) first human HMP series; Mergental et al. (2020; 440 citations) transplants discarded livers post-NMP.

What open problems exist?

Standard viability biomarkers lack consensus; cost-effectiveness for routine use unproven; long-term (>5y) outcomes in marginal grafts need larger RCTs.

Research Organ Transplantation Techniques and Outcomes with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Machine Perfusion for Liver Preservation with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers